Novavax COVID-19 vaccine, adjuvanted – FDA advisors discuss emergency use authorization request
June 7, 2022 - The Food and Drug Administration (FDA) convened a Vaccine and Biologic Products Advisory Committee (VRBPAC) to discuss an Emergency Use Authorization (EUA) request by Novavax for a vaccine to prevent COVID-19 in individuals 18 years of age and older.
Top